Skip to content
FrontierPicks

Covered

NXH · Bed Bath & Beyond

Conviction · Low · more likely to lag the S&P 500 over the next three months

Wrong if: a daily close above $1.67

Note written ·

Price against the kill line

24.6% clear of its kill line on the 13 November 2026 close.

How to read this

This note expects the shares to lag the market, so its kill line sits above the price: a close above the red mark would prove the view wrong. Prices run from low on the left to high on the right. The dot is where the stock closed on 13 November 2026, left of the mark while it is below the line; a dot right of the mark has closed through it.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

NXHBed Bath & Beyond
$1.67
$1.26
24.6%well clear

Three months against the kill line

NXH daily closes from 17 August 2026 to 13 November 2026, last $1.26, against its kill line: a daily close above $1.67. 17 August 2026: $4.2818 August 2026: $4.2619 August 2026: $4.2720 August 2026: $4.1721 August 2026: $4.1524 August 2026: $3.9025 August 2026: $4.0626 August 2026: $4.0127 August 2026: $3.9428 August 2026: $3.9331 August 2026: $3.931 September 2026: $3.692 September 2026: $3.823 September 2026: $3.894 September 2026: $3.958 September 2026: $3.859 September 2026: $3.8210 September 2026: $3.5511 September 2026: $3.5814 September 2026: $3.6215 September 2026: $3.3916 September 2026: $3.3417 September 2026: $3.3718 September 2026: $3.4721 September 2026: $3.4922 September 2026: $3.5423 September 2026: $3.3524 September 2026: $3.3025 September 2026: $3.2728 September 2026: $3.0929 September 2026: $2.9930 September 2026: $2.941 October 2026: $2.832 October 2026: $2.765 October 2026: $2.066 October 2026: $1.837 October 2026: $1.788 October 2026: $1.729 October 2026: $1.6912 October 2026: $1.6213 October 2026: $1.6314 October 2026: $1.6215 October 2026: $1.7116 October 2026: $1.5619 October 2026: $1.5020 October 2026: $1.5221 October 2026: $1.4022 October 2026: $1.4823 October 2026: $1.6426 October 2026: $1.5827 October 2026: $1.6028 October 2026: $1.5829 October 2026: $1.5530 October 2026: $1.532 November 2026: $1.693 November 2026: $1.694 November 2026: $1.715 November 2026: $1.676 November 2026: $1.669 November 2026: $1.5110 November 2026: $1.3611 November 2026: $1.3612 November 2026: $1.2613 November 2026: $1.26

Daily closes, to . Red: the kill line, a daily close above $1.67, on record since 11 November 2026. The shares are down 70.6% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close above $1.67, the 5 November 2026 close on the day of the third-quarter results, which would show the shares leading again. A raised 2027 revenue outlook above the $2.0 billion to $2.1 billion range would also show that.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Consumer Discretionary

Quarter to 30 September 2026, filed 5 November 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
509
Revenue, change on a year (%)
+98.0
Gross margin (%)
34.0
Operating margin (%)
−12.2
Free cash flow, four quarters ($M)
−139
Net cash, cash less debt ($M)
−112
Enterprise value to sales (×)
0.2
Free-cash-flow yield (%)
−100.3
All filed numbers

What Bed Bath & Beyond reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 509 +98.0 34.0 −12.2
first filed 361 +28.0 26.8 −11.9
first filed 248 +6.9 23.9 −7.3
first filed 273 −9.8 24.6 −4.8
first filed 257 −17.4 25.3 −4.8
first filed restated 282 −29.1 23.7 −4.4
Income Quarter to 30 September 2026, filed 5 November 2026
Pre-tax income ($M) −45.1
Net income ($M) four quarters: −103 −26.1
Diluted shares, change on a year (%) against the quarter to 30 September 2025 +57.3
Cash flow Four quarters to 30 September 2026, filed 5 November 2026
Operating cash flow ($M) −125
Capital spending ($M) 14.1
Free cash flow ($M) −139
Balance sheet At 30 September 2026, filed 5 November 2026
Cash and short-term investments ($M) 100
Debt ($M) long-term debt and finance leases plus short-term borrowings 213
Net cash, cash less debt ($M) −112
Deferred revenue ($M) +33.5% on a year 47.8
Backlog, orders not yet delivered ($M) Not reported
Receivables ($M) 50.5
Inventory ($M) 228
Shareholders' equity ($M) 292
Valuation At the 13 November 2026 close, filed figures to 5 November 2026
Market value ($M) 139
Enterprise value, market value plus net debt ($M) 251
Enterprise value to sales (×) 0.2
Enterprise value to operating income (×) Not meaningful
Price to earnings (×) Not meaningful
Price to book value (×) 0.5
Free-cash-flow yield (%) −100.3

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 14.8% of shares outstanding sold short, 2.6 days of average trading to cover, +25.4% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $1.0M $0
12 monthsfrom $1.5M $63K

The thesis

Neighborhood Intelligence, formerly Bed Bath & Beyond, is more likely to lag the S&P 500 over the next three months. Most of its growth was bought, it still loses money, and the share count is set to rise. The 2027 revenue target of $2.0 billion to $2.1 billion and the quarterly loss rate settle whether the turnaround funds itself.

Third-quarter revenue was $509.3 million, reported on 5 November 2026 (Form 8-K exhibit 99.1). That sits inside the company's $505 million to $525 million guidance range but near the floor. The release attributes $229 million of the year-over-year revenue gain to acquisitions and $23 million to the core business. Net loss was $26.1 million, or $0.28 per share.

The market has marked the shares down since the report. They closed at $1.71 on 4 November 2026, $1.51 on 9 November 2026 and $1.36 on both 10 November 2026 and 11 November 2026. The $1.36 close is a 52-week closing low and sits 69.4% below the close of 13 August 2026 ($4.44). Company news lists a Maxim Group downgrade to Hold on 9 November 2026.

Bullish and bearish views on Bed Bath & Beyond, Inc.

The bull case on Bed Bath & Beyond, Inc. (NXH), in brief: revenue landed inside guidance. The bear case: growth depends on acquisitions.

Bull case

  • Revenue landed inside guidance. Third-quarter revenue of $509.3 million was up 98.0% from a year earlier (5 November 2026 release). The result met a guidance range of $505 million to $525 million.
  • Gross margin widened sharply. Gross profit was $172.9 million, about 34% of revenue, against 25.3% a year earlier (Form 10-Q for the period ended 30 September 2026).
  • The 2027 targets are specific. The release guides 2027 revenue to $2.0 billion to $2.1 billion at a 33% to 34% gross margin. It targets positive cash flow by the second half of 2027.
  • Cost cuts are continuing. The 5 October 2026 business update reported more than $50 million of selling, general and administrative savings this year and at least $30 million more identified (Form 8-K).
  • An insider bought in the offering. Executive Chairman and Chief Executive Officer Marcus Lemonis bought 362,319 shares at $2.76 on 6 October 2026 (SEC Form 4). That price is double the 11 November 2026 close.
  • Short interest is high. StockAnalysis listed 13.01 million shares sold short, 13.64% of shares outstanding, on 21 October 2026. A rally would force some of those positions to close.

Bear case

  • Growth depends on acquisitions. Of the quarter's revenue gain, $229 million came from acquired businesses and $23 million from the core business (5 November 2026 release). Core growth at that pace does not reach the 2027 target on its own.
  • The company still loses money. Third-quarter net loss was $26.1 million and adjusted earnings before interest, taxes, depreciation and amortization was negative $26.5 million. Nine-month free cash flow was negative $130.4 million (5 November 2026 release).
  • Cash is thin against the burn. Cash and equivalents were $100.4 million and restricted cash $26.8 million at 30 September 2026 (Form 10-Q). The $45.5 million equity financing closed on 6 October 2026. Inventory was $227.8 million, with $118 million of asset-based loan borrowings against it.
  • Dilution is built in. The October financing carries warrants for up to 16,123,189 shares at a $3.45 exercise price, exercisable six months after issuance (Form 424B5). Shares outstanding were 98.626 million at 30 September 2026. Stockholders approved conversion-share issuance for the 5.00% senior notes due 2033 on 24 September 2026.
  • No fourth-quarter guidance was given. The 5 November 2026 release has no fourth-quarter revenue range, so the next measured test is the full-year report.
  • Deals and finance leadership keep changing. The F9 purchase agreement ended in September and the Fathom Holdings merger ended on 5 October 2026. An interim chief financial officer was appointed on 5 October 2026 (Form 8-K).

Price setup

The shares closed at $1.36 on 11 November 2026, equal to the 52-week closing low set on 10 November 2026. The 52-week intraday high is $7.72, reached on 22 January 2026. The last close is 82.4% below it.

The 50-day average of adjusted closes was $2.41 and the 200-day average $4.49 as of 11 November 2026. The shares trade below both. The 3-month price change is −69.4%.

The October financing priced at $2.76 per share, and the warrant exercise price is $3.45. Both sit well above the 11 November 2026 close.

Catalysts ahead

  • ~31 December 2026 (est.): Expected completion of store closures. Execution of the closures and the $30 million of identified savings sets the pace of the quarterly loss.
  • ~6 April 2027 (est.): October financing warrants become exercisable. Exercise at the $3.45 strike would add up to 16,123,189 shares, but only if the shares trade above that price.

What would change the view

A daily close above $1.67, the 5 November 2026 close on the day of the third-quarter results, which would show the shares leading again. A raised 2027 revenue outlook above the $2.0 billion to $2.1 billion range would also show that.

What it trades with

The shares move on company-specific financing, acquisition and turnaround news. No current theme group carries the name. Home-goods and discretionary retail demand sets the revenue backdrop. Small-cap retail stocks with high short interest tend to move together on risk appetite. Only a handful of sessions have traded since the report, a sample too small to draw a conclusion about how the market is reading it.

The evidence, claim by claim (8)
  1. Third-quarter revenue was $509.3 million, up 98.0% year over year; gross profit $172.9 million (about 34% of revenue); net loss $26.1 million, or $0.28 per share. Form 8-K exhibit 99.1 earnings release, SEC EDGAR · as of
  2. Revenue growth drew $229 million from acquisitions and $23 million from the core business. Form 8-K exhibit 99.1 earnings release, SEC EDGAR · as of
  3. Cash and equivalents were $100.4 million and restricted cash $26.8 million; inventories $227.8 million; nine-month free cash flow was negative $130.4 million. Form 8-K exhibit 99.1 and Form 10-Q, SEC EDGAR · as of
  4. The company guided full-year 2027 revenue to $2.0 billion to $2.1 billion at a 33% to 34% gross margin and targeted positive cash flow by the second half of 2027; no fourth-quarter guidance was given. Form 8-K exhibit 99.1 earnings release, SEC EDGAR · as of
  5. A $45.5 million equity financing priced at $2.76 per share with warrants at a $3.45 exercise price for up to 16,123,189 shares closed on 6 October 2026. Company press release, Form 424B5 · as of
  6. Marcus Lemonis, Executive Chairman and CEO, made an open-market purchase of 362,319 shares at $2.76. SEC Form 4 · as of
  7. Neighborhood Intelligence and Fathom Holdings mutually terminated their merger agreement. Form 8-K and joint press release, SEC EDGAR · as of
  8. Short interest was 13.01 million shares, 13.64% of shares outstanding. StockAnalysis, NXH statistics · as of

Sources

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X